alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator

British Journal of Pharmacology
K OritoT Kambe

Abstract

1. Antagonistic properties of OPC-28326 ([4-(N-methyl-2-phenylethylamino)-1-(3,5-dimethyl-4-propionyl-aminobenzoyl)] piperidine hydrochloride monohydrate), a selective peripheral vasodilator, were investigated by analysing the data from functional studies in various tissues from the rat and binding studies of the drug to alpha(2)-adrenoceptor subtypes. 2. Using a human recombinant receptor and rat kidney cortex, we found that OPC-28326 displays affinities to alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptors with K(i) values of 2040, 285, and 55 nM, respectively. The K(i) values of yohimbine for alpha(2A)-, alpha(2B)-, and alpha(2C)-adrenoceptors were 3.0, 2.0 and 11.0 nM, respectively. 3. B-HT 920, an alpha(2)-adrenoceptor agonist, produced a pressor response via peripheral postsynaptic alpha(2)-adrenoceptor stimulation (thought to be an alpha(2B)-subtype) in a reserpine-pretreated pithed rat preparation. OPC-28326 (3 - 30 mg kg(-1), i.v.) and yohimbine (0.3 - 3 mg kg(-1), i.v.) caused dose-dependent rightward shift in the pressor dose-response curve induced by B-HT 920. The apparent pA(2) values were 1.55 (0.87 - 2.75, 95% confidence interval) and 0.11 (0.06 - 0.21) mg kg(-1), respectively. The potency of OPC-28326 was about ...Continue Reading

References

Oct 1, 1990·British Journal of Pharmacology·S Connaughton, J R Docherty
Feb 1, 1991·Trends in Pharmacological Sciences·J K HarrisonK R Lynch
May 1, 1986·Journal of Cardiovascular Pharmacology·F HentrichD Greschuchna
Jan 1, 1993·Annual Review of Pharmacology and Toxicology·R R RuffoloJ P Hieble
Nov 1, 1995·Naunyn-Schmiedeberg's Archives of Pharmacology·G J Molderings, M Göthert
Jun 1, 1997·Trends in Pharmacological Sciences·E MacDonaldM Scheinin
Dec 16, 1998·European Journal of Pharmacology·J R Docherty
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD

❮ Previous
Next ❯

Citations

Nov 15, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Suneet MehrotraAntoinette Maassenvandenbrink
May 30, 2009·Neurochemistry International·Klára GyiresPéter Mátyus
Jan 16, 2007·British Journal of Pharmacology·M D Tricklebank
Sep 1, 2021·Clinical Pharmacology in Drug Development·Stefanie KapsaChristiane Otto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.